P23975 SC6A2_HUMAN
Gene name: SLC6A2
Protein name: Sodium-dependent noradrenaline transporter
List of molecules and drugs that target protein P23975
# | DrugDomain Data | DrugBank Accession | Name | Drug action | Affinity data | InChI Key | SMILES |
---|---|---|---|---|---|---|---|
1 | P23975_DB00182 | DB00182 | Amphetamine | agonist | Ki(nM) = 7.1 | KWTSXDURSIMDCE-UHFFFAOYSA-N | CC(N)CC1=CC=CC=C1 |
2 | P23975_DB00191 | DB00191 | Phentermine | inhibitor | DHHVAGZRUROJKS-UHFFFAOYSA-N | CC(C)(N)CC1=CC=CC=C1 | |
3 | P23975_DB00193 | DB00193 | Tramadol | inhibitor | IC50(nM) = 790.0 | TVYLLZQTGLZFBW-UHFFFAOYSA-N | COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C |
4 | P23975_DB00226 | DB00226 | Guanadrel | partial agonist | HPBNRIOWIXYZFK-UHFFFAOYSA-N | NC(N)=NCC1COC2(CCCCC2)O1 | |
5 | P23975_DB00234 | DB00234 | Reboxetine | inhibitor | Ki(nM) = 0.3 IC50(nM) = 2.0 | CBQGYUDMJHNJBX-RTBURBONSA-N | [H][C@@]1(CNCCO1)[C@H](OC1=CC=CC=C1OCC)C1=CC=CC=C1 |
6 | P23975_DB00245 | DB00245 | Benzatropine | inhibitor | GIJXKZJWITVLHI-PMOLBWCYSA-N | [H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C | |
7 | P23975_DB00285 | DB00285 | Venlafaxine | inhibitor | Ki(nM) = 210.0 IC50(nM) = 149.0 Kd(nM) = 1060.0 | PNVNVHUZROJLTJ-UHFFFAOYSA-N | COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1 |
8 | P23975_DB00289 | DB00289 | Atomoxetine | inhibitor | IC50(nM) = 3.0 Kd(nM) = 2.0 | VHGCDTVCOLNTBX-QGZVFWFLSA-N | CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1 |
9 | P23975_DB00321 | DB00321 | Amitriptyline | inhibitor | Ki(nM) = 13.3 | KRMDCWKBEZIMAB-UHFFFAOYSA-N | CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12 |
10 | P23975_DB00344 | DB00344 | Protriptyline | inhibitor | Ki(nM) = 1.41 IC50(nM) = 1.7 Kd(nM) = 1.4 | BWPIARFWQZKAIA-UHFFFAOYSA-N | CNCCCC1C2=CC=CC=C2C=CC2=CC=CC=C12 |
11 | P23975_DB00408 | DB00408 | Loxapine | binder | XJGVXQDUIWGIRW-UHFFFAOYSA-N | CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2 | |
12 | P23975_DB00422 | DB00422 | Methylphenidate | inhibitor | Ki(nM) = 340.0 IC50(nM) = 61.0 | DUGOZIWVEXMGBE-UHFFFAOYSA-N | COC(=O)C(C1CCCCN1)C1=CC=CC=C1 |
13 | P23975_DB00454 | DB00454 | Meperidine | inhibitor | XADCESSVHJOZHK-UHFFFAOYSA-N | CCOC(=O)C1(CCN(C)CC1)C1=CC=CC=C1 | |
14 | P23975_DB00458 | DB00458 | Imipramine | inhibitor | Ki(nM) = 16.0 IC50(nM) = 74.0 | BCGWQEUPMDMJNV-UHFFFAOYSA-N | CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12 |
15 | P23975_DB00476 | DB00476 | Duloxetine | inhibitor | Ki(nM) = 4.6 IC50(nM) = 1.6 | ZEUITGRIYCTCEM-KRWDZBQOSA-N | CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1 |
16 | P23975_DB00514 | DB00514 | Dextromethorphan | inhibitor | MKXZASYAUGDDCJ-NJAFHUGGSA-N | [H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2 | |
17 | P23975_DB00540 | DB00540 | Nortriptyline | inhibitor | Ki(nM) = 1.49 | PHVGLTMQBUFIQQ-UHFFFAOYSA-N | CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12 |
18 | P23975_DB00543 | DB00543 | Amoxapine | inhibitor | Ki(nM) = 16.0 | QWGDMFLQWFTERH-UHFFFAOYSA-N | ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1 |
19 | P23975_DB00579 | DB00579 | Mazindol | inhibitor | Ki(nM) = 0.46 IC50(nM) = 0.92 | ZPXSCAKFGYXMGA-UHFFFAOYSA-N | OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1 |
20 | P23975_DB00715 | DB00715 | Paroxetine | inhibitor | Ki(nM) = 40.0 IC50(nM) = 100.0 Kd(nM) = 40.0 | AHOUBRCZNHFOSL-YOEHRIQHSA-N | FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1 |
21 | P23975_DB00726 | DB00726 | Trimipramine | inhibitor | Ki(nM) = 2450.0 | ZSCDBOWYZJWBIY-UHFFFAOYSA-N | CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12 |
22 | P23975_DB00830 | DB00830 | Phenmetrazine | inhibitor | OOBHFESNSZDWIU-UHFFFAOYSA-N | CC1NCCOC1C1=CC=CC=C1 | |
23 | P23975_DB00852 | DB00852 | Pseudoephedrine | inhibitor | KWGRBVOPPLSCSI-WCBMZHEXSA-N | CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 | |
24 | P23975_DB00907 | DB00907 | Cocaine | inhibitor | Ki(nM) = 108.0 IC50(nM) = 186.0 EC50(nM) = 385.0 | ZPUCINDJVBIVPJ-LJISPDSOSA-N | [H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C |
25 | P23975_DB00924 | DB00924 | Cyclobenzaprine | inhibitor | JURKNVYFZMSNLP-UHFFFAOYSA-N | CN(C)CCC=C1C2=CC=CC=C2C=CC2=CC=CC=C12 | |
26 | P23975_DB00934 | DB00934 | Maprotiline | inhibitor | QSLMDECMDJKHMQ-UHFFFAOYSA-N | CNCCCC12CCC(C3=CC=CC=C13)C1=CC=CC=C21 | |
27 | P23975_DB00937 | DB00937 | Diethylpropion | inhibitor | XXEPPPIWZFICOJ-UHFFFAOYSA-N | CCN(CC)C(C)C(=O)C1=CC=CC=C1 | |
28 | P23975_DB00988 | DB00988 | Dopamine | inhibitor | Ki(nM) = 323.0 IC50(nM) = 6.6 | VYFYYTLLBUKUHU-UHFFFAOYSA-N | NCCC1=CC(O)=C(O)C=C1 |
29 | P23975_DB01104 | DB01104 | Sertraline | inhibitor | IC50(nM) = 825.0 Kd(nM) = 420.0 | VGKDLMBJGBXTGI-SJCJKPOMSA-N | CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12 |
30 | P23975_DB01105 | DB01105 | Sibutramine | inhibitor | UNAANXDKBXWMLN-UHFFFAOYSA-N | CC(C)CC(N(C)C)C1(CCC1)C1=CC=C(Cl)C=C1 | |
31 | P23975_DB01114 | DB01114 | Chlorpheniramine | inhibitor | SOYKEARSMXGVTM-UHFFFAOYSA-N | CN(C)CCC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1 | |
32 | P23975_DB01142 | DB01142 | Doxepin | inhibitor | ODQWQRRAPPTVAG-UHFFFAOYSA-N | [H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12 | |
33 | P23975_DB01149 | DB01149 | Nefazodone | inhibitor | Ki(nM) = 360.0 Kd(nM) = 360.0 | VRBKIVRKKCLPHA-UHFFFAOYSA-N | CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1 |
34 | P23975_DB01151 | DB01151 | Desipramine | inhibitor | Ki(nM) = 0.49 IC50(nM) = 0.93 Kd(nM) = 0.83 | HCYAFALTSJYZDH-UHFFFAOYSA-N | CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12 |
35 | P23975_DB01156 | DB01156 | Bupropion | inhibitor | Ki(nM) = 3642.0 IC50(nM) = 443.0 | SNPPWIUOZRMYNY-UHFFFAOYSA-N | CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1 |
36 | P23975_DB01170 | DB01170 | Guanethidine | inducer | ACGDKVXYNVEAGU-UHFFFAOYSA-N | NC(N)=NCCN1CCCCCCC1 | |
37 | P23975_DB01173 | DB01173 | Orphenadrine | inhibitor | QVYRGXJJSLMXQH-UHFFFAOYSA-N | CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1C | |
38 | P23975_DB01175 | DB01175 | Escitalopram | inhibitor | WSEQXVZVJXJVFP-FQEVSTJZSA-N | CN(C)CCC[C@]1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1 | |
39 | P23975_DB01221 | DB01221 | Ketamine | inhibitor | YQEZLKZALYSWHR-UHFFFAOYSA-N | CNC1(CCCCC1=O)C1=CC=CC=C1Cl | |
40 | P23975_DB01242 | DB01242 | Clomipramine | inhibitor | Ki(nM) = 38.0 IC50(nM) = 65.0 | GDLIGKIOYRNHDA-UHFFFAOYSA-N | CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2 |
41 | P23975_DB01364 | DB01364 | Ephedrine | inverse agonist | KWGRBVOPPLSCSI-WPRPVWTQSA-N | CN[C@@H](C)[C@H](O)C1=CC=CC=C1 | |
42 | P23975_DB01442 | DB01442 | MMDA | negative modulator | YQYUWUKDEVZFDB-UHFFFAOYSA-N | COC1=CC(CC(C)N)=CC2=C1OCO2 | |
43 | P23975_DB01454 | DB01454 | Midomafetamine | negative modulator | Ki(nM) = 10000.0 IC50(nM) = 405.0 EC50(nM) = 1000.0 | SHXWCVYOXRDMCX-UHFFFAOYSA-N | CNC(C)CC1=CC2=C(OCO2)C=C1 |
44 | P23975_DB01576 | DB01576 | Dextroamphetamine | negative modulator | EC50(nM) = 7.1 | KWTSXDURSIMDCE-QMMMGPOBSA-N | C[C@H](N)CC1=CC=CC=C1 |
45 | P23975_DB01577 | DB01577 | Metamfetamine | negative modulator | MYWUZJCMWCOHBA-VIFPVBQESA-N | CN[C@@H](C)CC1=CC=CC=C1 | |
46 | P23975_DB01579 | DB01579 | Phendimetrazine | negative modulator | MFOCDFTXLCYLKU-CMPLNLGQSA-N | C[C@H]1[C@@H](OCCN1C)C1=CC=CC=C1 | |
47 | P23975_DB04821 | DB04821 | Nomifensine | n/a | Ki(nM) = 3.8 | XXPANQJNYNUNES-UHFFFAOYSA-N | CN1CC(C2=CC=CC=C2)C2=C(C1)C(N)=CC=C2 |
48 | P23975_DB04836 | DB04836 | Amineptine | n/a | ONNOFKFOZAJDHT-UHFFFAOYSA-N | OC(=O)CCCCCCNC1C2=CC=CC=C2CCC2=CC=CC=C12 | |
49 | P23975_DB04840 | DB04840 | Debrisoquine | inducer | JWPGJSVJDAJRLW-UHFFFAOYSA-N | NC(=N)N1CCC2=CC=CC=C2C1 | |
50 | P23975_DB04889 | DB04889 | Bicifadine | n/a | IC50(nM) = 55.0 | OFYVIGTWSQPCLF-UHFFFAOYSA-N | CC1=CC=C(C=C1)C12CC1CNC2 |
51 | P23975_DB04896 | DB04896 | Milnacipran | inhibitor | Ki(nM) = 22.0 IC50(nM) = 5500.0 | GJJFMKBJSRMPLA-UHFFFAOYSA-N | CCN(CC)C(=O)C1(CC1CN)C1=CC=CC=C1 |
52 | P23975_DB05642 | DB05642 | DDP-225 | n/a | SAURKKOJWIFYSR-UHFFFAOYSA-N | O.Cl.CC1=CC2=C(N=C(N=C2S1)N1CCNCC1)C1=CC=CC=C1F | |
53 | P23975_DB05964 | DB05964 | Amitifadine | n/a | BSMNRYCSBFHEMQ-KCJUWKMLSA-N | [H][C@]12C[C@]1(CNC2)C1=CC(Cl)=C(Cl)C=C1 | |
54 | P23975_DB06148 | DB06148 | Mianserin | inhibitor | UEQUQVLFIPOEMF-UHFFFAOYSA-N | CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21 | |
55 | P23975_DB06156 | DB06156 | Tesofensine | n/a | VCVWXKKWDOJNIT-ZOMKSWQUSA-N | CCOC[C@H]1[C@H]2CC[C@@H](C[C@@H]1C1=CC(Cl)=C(Cl)C=C1)N2C | |
56 | P23975_DB06204 | DB06204 | Tapentadol | inhibitor | KWTWDQCKEHXFFR-SMDDNHRTSA-N | CC[C@H]([C@@H](C)CN(C)C)C1=CC(O)=CC=C1 | |
57 | P23975_DB06333 | DB06333 | Trodusquemine | n/a | WUJVPODXELZABP-FWJXURDUSA-N | [H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@@]4([H])C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)NCCCNCCCCNCCCN)[C@H](C)CC[C@@H](OS(O)(=O)=O)C(C)C | |
58 | P23975_DB06700 | DB06700 | Desvenlafaxine | inhibitor | Ki(nM) = 531.3 IC50(nM) = 538.0 | KYYIDSXMWOZKMP-UHFFFAOYSA-N | CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1 |
59 | P23975_DB06701 | DB06701 | Dexmethylphenidate | inhibitor | DUGOZIWVEXMGBE-CHWSQXEVSA-N | [H][C@@](C(=O)OC)(C1=CC=CC=C1)[C@@]1([H])CCCCN1 | |
60 | P23975_DB08918 | DB08918 | Levomilnacipran | inhibitor | IC50(nM) = 40.0 | GJJFMKBJSRMPLA-DZGCQCFKSA-N | CCN(CC)C(=O)[C@]1(C[C@H]1CN)C1=CC=CC=C1 |
61 | P23975_DB09068 | DB09068 | Vortioxetine | blocker | YQNWZWMKLDQSAC-UHFFFAOYSA-N | CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1 | |
62 | P23975_DB09167 | DB09167 | Dosulepin | inhibitor | PHTUQLWOUWZIMZ-GZTJUZNOSA-N | CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12 | |
63 | P23975_DB09185 | DB09185 | Viloxazine | inhibitor | Ki(nM) = 155.0 Kd(nM) = 155.0 | YWPHCCPCQOJSGZ-UHFFFAOYSA-N | CCOC1=CC=CC=C1OCC1CNCCO1 |
64 | P23975_DB09225 | DB09225 | Zotepine | antagonist | HDOZVRUNCMBHFH-UHFFFAOYSA-N | CN(C)CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12 | |
65 | P23975_DB12305 | DB12305 | Dasotraline | n/a | SRPXSILJHWNFMK-MEDUHNTESA-N | N[C@@H]1CC[C@@H](C2=CC=C(Cl)C(Cl)=C2)C2=CC=CC=C12 | |
66 | P23975_DB13931 | DB13931 | Netarsudil | inhibitor | OURRXQUGYQRVML-AREMUKBSSA-N | CC1=CC(C)=C(C=C1)C(=O)OCC1=CC=C(C=C1)[C@@H](CN)C(=O)NC1=CC=C2C=NC=CC2=C1 | |
67 | P23975_DB14754 | DB14754 | Solriamfetol | n/a | UCTRAOBQFUDCSR-SECBINFHSA-N | N[C@@H](COC(N)=O)CC1=CC=CC=C1 | |
68 | P23975_DB16629 | DB16629 | Serdexmethylphenidate | inhibitor | UBZPNQRBUOBBLN-PWRODBHTSA-N | [H][C@@]1(CCCCN1C(=O)OC[N+]1=CC=CC(=C1)C(=O)N[C@@H](CO)C([O-])=O)[C@H](C(=O)OC)C1=CC=CC=C1 |